Company: XOMAP
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001104659-25-109782
Chunk: 6

Company: XOMA Royalty Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1C
Chunk 6
---
Preferred stock dividend accrual ​​ 1,368​​ 1,368Current portion of long-term debt​​ 14,345​​ 11,394Contingent value rights liabilities - current portion​​ 1,976​​ —Total current liabilities​  28,305​  24,374Unearned revenue recognized under units-of-revenue method – long-term​  3,473​  4,410Exarafenib milestone contingent consideration (Note 6)​​ 3,500​​ 3,214Long-term operating lease liabilities ​​ 20,678​​ 483Long-term debt​​ 94,382​​ 106,875Contingent value rights liabilities – long-term​​ 4,807​​ —Deferred tax liability​​ 49​​ —Total liabilities​  155,194​  139,356​​​​​​​Commitments and Contingencies (Note 11)​​​​​​​​​​​​​Convertible preferred stock, $0.05 par value, 5,003 shares authorized, issued and outstanding as of September 30, 2025 and December 31, 2024​  20,019​  20,019​​​​​​​Stockholders’ equity:​​​​​​8.625% Series A cumulative, perpetual preferred stock, $0.05 par value, 984,000 shares authorized, issued and outstanding as of September 30, 2025 and December 31, 2024​​ 49​​ 498.375% Series B cumulative, perpetual preferred stock, $0.05 par value, 3,600 shares authorized, 1,600 shares issued and outstanding as of September 30, 2025 and December 31, 2024​​ —​  —Common stock, $0.0075 par value, 277,333,332 shares authorized, 12,310,300 and 11,952,377 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively​  92​  90Additional paid-in capital​  1,301,542​  1,298,747Accumulated other comprehensive income​​ 121​​ 73Accumulated deficit​  (1,213,866)​  (1,237,057)Total stockholders’ equity​  87,938​  61,902Total liabilities, convertible preferred stock and stockholders’ equity​$